Cargando…
Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy
The development of stable and long-circulating liposomes provides protection of the drug cargo from degradation and increases tumor drug delivery, leading to the design of liposome formulations with great potential in cancer therapy. However, despite the sound pharmacologic basis, many liposomal as...
Autores principales: | La-Beck, Ninh M., Gabizon, Alberto A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382151/ https://www.ncbi.nlm.nih.gov/pubmed/28428790 http://dx.doi.org/10.3389/fimmu.2017.00416 |
Ejemplares similares
-
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
por: La-Beck, Ninh M., et al.
Publicado: (2021) -
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
por: La-Beck, Ninh M., et al.
Publicado: (2019) -
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model
por: Islam, Md. Rakibul, et al.
Publicado: (2023) -
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma model
por: Islam, Md. Rakibul, et al.
Publicado: (2022) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
por: Gabizon, Alberto, et al.
Publicado: (2023)